Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-041096
Filing Date
2021-06-16
Accepted
2021-06-16 19:14:39
Documents
2
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2858
2 EX-24 DOCUMENT attachment1.htm EX-24 3374
  Complete submission text file 0001209191-21-041096.txt   7609
Mailing Address 5203 BRISTOL INDUSTRIAL WAY BUFORD GA 30518
Business Address
BRAWLEY OTIS W (Reporting) CIK: 0001213029 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40502 | Film No.: 211022837

Mailing Address 400 EAST JAMIE COURT SUITE 301 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 301 SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Issuer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations